Group Holdings (Sbs) Adviso... Net Worth

The estimated Net Worth of Group Holdings (Sbs) Adviso... is at least $6.51 milliard dollars as of 12 October 2021. Group Adviso owns over 545,416 units of Convey Parent stock worth over $629,494,012 and over the last 13 years Group sold CNVY stock worth over $5,880,025,755.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Group Adviso CNVY stock SEC Form 4 insiders trading

Group has made over 120 trades of the Convey Parent stock since 2012, according to the Form 4 filled with the SEC. Most recently Group sold 545,416 units of CNVY stock worth $11,840,981 on 12 October 2021.

The largest trade Group's ever made was selling 39,300,311 units of Convey Parent stock on 18 December 2012 worth over $236,587,872. On average, Group trades about 1,888,367 units every 22 days since 2012. As of 12 October 2021 Group still owns at least 59,894,768 units of Convey Parent stock.

You can see the complete history of Group Adviso stock trades at the bottom of the page.

Insiders trading at Convey Parent

Over the last 3 years, insiders at Convey Parent have traded over $22,452,340 worth of Convey Parent stock and bought 122,260 units worth $1,591,721 . The most active insiders traders include Group Holdings (Sbs) Adviso..., Paul Campanelli et Stephen C Farrell. On average, Convey Parent executives and independent directors trade stock every 64 days with the average trade being worth of $2,835,419. The most recent stock trade was executed by Susana Pichardo on 7 September 2022, trading 71,651 units of CNVY stock currently worth $752,336.

What does Convey Parent do?

Complete history of Group Adviso stock trades at Aerie Pharmaceuticals Inc, Caesars Entertainment Inc, Caredx Inc, Collegium Pharmaceutical Inc, LPL Inc, Macrogenics Inc, Norwegian Cruise Line, Otonomy Inc, Sabre Corp, Tandem Diabetes Care Inc, Ultragenyx Pharmaceutical, Veracyte Inc, C3.ai Inc, Graphic Packaging Co, Superior Industries International, Taylor Morrison Home, Zimmer Biomet Inc, TPG RE Finance Trust Inc, Zscaler Inc, Norwegian Cruise Line Ltd, Entasis Therapeutics Inc, Allogene Therapeutics Inc, Progyny Inc, Accel Entertainment Inc, Magnolia Oil & Gas Corp, Trevi Therapeutics, Vaxcyte, Fusion Pharmaceuticals, Satsuma Pharmaceuticals, McAfee et Convey Parent

Convey Parent executives and stock owners

Convey Parent executives and other stock owners filed with the SEC include:

• Stephen C. Farrell CFA,
  CEO & Director
• John E. Steele,
  Exec. VP of Technology
• Kyle Stern,
  Exec. VP
• Tom Pelegrin,
  Sr. VP & Chief Revenue Officer
• Stephanie Jones,
  Pres of Advanced Plan Admin.
• Michele Henderson,
  Sr. VP of HR
• Deborah Johnson,
  Chief Compliance Officer
• Giray Akar,
  Chief Technology Officer
• Susana E. Pichardo,
  Sr. VP of Accounting
• Timothy Fairbanks,
  Exec. VP & CFO
• Arjun Aggarwal,
  Advisor
• Stephen C Farrell,
  CHIEF EXECUTIVE OFFICER
• Paul Campanelli,
  Director
• Sharad Mansukani,
  Director
• William Carl Whitmer,
  Director
• Group Holdings (Sbs) Adviso...,
  
• Susana Pichardo,
  SVP, Accounting
• Timothy Fairbanks,
  Chief Financial Officer & EVP
• John E. Steele,
  EVP, Technology
• Kyle Stern,
  Mng Partner, HealthScape & EVP